Certara Products Archives

Press Release

Certara Reports Second Quarter 2025 Financial Results

RADNOR, PA— August 6, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…

CertaraAugust 6, 2025

Webinar

De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator

CertaraAugust 5, 2025

Blog

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…

CertaraJuly 31, 2025

On-Demand Webinar

Three Approaches to AI Adoption in Regulatory Writing

CoAuthor™ is a GenAI-driven regulatory writing platform, seamlessly integrated with Microsoft Word. By providing efficiency,…

CertaraJuly 23, 2025

Guide

How to Create a Data Validation Plan in Clinical Data Management

Download our guide to creating a data validation plan in clinical data management, the ultimate…

CertaraJuly 21, 2025

Webinar

Needle in the Haystack: The Role of Data Fabrics in Successful AI Implementation

CertaraJuly 18, 2025

Webinar

Pirana Tips and Tricks – Report Object Generation in Pirana

CertaraJuly 1, 2025

Blog

The Reference-scaled Average Bioequivalence (RSABE) Approach

We examine the Reference-scaled Average Bioequivalence (RSABE) approach for generic drug development and how it…

CertaraJuly 1, 2025

Blog

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

June 30, 2025 Drug development is increasingly defined by its complexity. Teams must navigate rising…

CertaraJune 30, 2025

Blog

Maintain & Adapt Pharma Market Access Digital Tools Using Feedback

Maintain the credibility of your pharma market access digital tools through continuous updates based on…

CertaraJune 30, 2025

Certara Products

Certara Reports Second Quarter 2025 Financial Results

De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

Three Approaches to AI Adoption in Regulatory Writing

How to Create a Data Validation Plan in Clinical Data Management

Needle in the Haystack: The Role of Data Fabrics in Successful AI Implementation

Pirana Tips and Tricks – Report Object Generation in Pirana

The Reference-scaled Average Bioequivalence (RSABE) Approach

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

Maintain & Adapt Pharma Market Access Digital Tools Using Feedback

Newsletter sign up

Quick links

Solutions

Contact